DT
This startup develops targeted oncology therapies by employing biomarker identification techniques to create personalized treatment plans based on individual tumor profiles. Their approach addresses the issue of ineffective cancer treatments by ensuring patients receive therapies specifically suited to their unique cancer characteristics.
Updated 4 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- This startup develops targeted oncology therapies by employing biomarker identification techniques to create personalized treatment plans based on individual tumor profiles. Their approach addresses the issue of ineffective cancer treatments by ensuring patients receive therapies specifically suited to their unique cancer characteristics.